<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kulsuptrakul J</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>NIDA NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>Edward Mallinckrodt Jr. Foundation</funding><funding>National Institute on Drug Abuse</funding><funding>National Institute of General Medical Sciences</funding><funding>NIGMS NIH HHS</funding><pagination>e84108</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10359095</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>Inflammasomes are cytosolic innate immune complexes that assemble upon detection of diverse pathogen-associated cues and play a critical role in host defense and inflammatory pathogenesis. Here, we find that the human inflammasome-forming sensor CARD8 senses HIV-1 infection via site-specific cleavage of the CARD8 N-terminus by the HIV protease (HIV-1&lt;sup>PR&lt;/sup>). HIV-1&lt;sup>PR&lt;/sup> cleavage of CARD8 induces pyroptotic cell death and the release of pro-inflammatory cytokines from infected cells, processes regulated by Toll-like receptor stimulation prior to viral infection. In acutely infected cells, CARD8 senses the activity of both de novo translated HIV-1&lt;sup>PR&lt;/sup> and packaged HIV-1&lt;sup>PR&lt;/sup> that is released from the incoming virion. Moreover, our evolutionary analyses reveal that the HIV-1&lt;sup>PR&lt;/sup> cleavage site in human CARD8 arose after the divergence of chimpanzees and humans. Although chimpanzee CARD8 does not recognize proteases from HIV or simian immunodeficiency viruses from chimpanzees (SIVcpz), SIVcpz does cleave human CARD8, suggesting that SIVcpz was poised to activate the human CARD8 inflammasome prior to its cross-species transmission into humans. Our findings suggest a unique role for CARD8 inflammasome activation in response to lentiviral infection of humans.</pubmed_abstract><journal>eLife</journal><pubmed_title>A human-specific motif facilitates CARD8 inflammasome activation after HIV-1 infection.</pubmed_title><pmcid>PMC10359095</pmcid><funding_grant_id>DP2 AI154432</funding_grant_id><funding_grant_id>T32 GM136534</funding_grant_id><funding_grant_id>DP2 AI 154432-01</funding_grant_id><funding_grant_id>T32 GM007270</funding_grant_id><funding_grant_id>DP1 DA051110</funding_grant_id><pubmed_authors>Turcotte EA</pubmed_authors><pubmed_authors>Kulsuptrakul J</pubmed_authors><pubmed_authors>Emerman M</pubmed_authors><pubmed_authors>Mitchell PS</pubmed_authors></additional><is_claimable>false</is_claimable><name>A human-specific motif facilitates CARD8 inflammasome activation after HIV-1 infection.</name><description>Inflammasomes are cytosolic innate immune complexes that assemble upon detection of diverse pathogen-associated cues and play a critical role in host defense and inflammatory pathogenesis. Here, we find that the human inflammasome-forming sensor CARD8 senses HIV-1 infection via site-specific cleavage of the CARD8 N-terminus by the HIV protease (HIV-1&lt;sup>PR&lt;/sup>). HIV-1&lt;sup>PR&lt;/sup> cleavage of CARD8 induces pyroptotic cell death and the release of pro-inflammatory cytokines from infected cells, processes regulated by Toll-like receptor stimulation prior to viral infection. In acutely infected cells, CARD8 senses the activity of both de novo translated HIV-1&lt;sup>PR&lt;/sup> and packaged HIV-1&lt;sup>PR&lt;/sup> that is released from the incoming virion. Moreover, our evolutionary analyses reveal that the HIV-1&lt;sup>PR&lt;/sup> cleavage site in human CARD8 arose after the divergence of chimpanzees and humans. Although chimpanzee CARD8 does not recognize proteases from HIV or simian immunodeficiency viruses from chimpanzees (SIVcpz), SIVcpz does cleave human CARD8, suggesting that SIVcpz was poised to activate the human CARD8 inflammasome prior to its cross-species transmission into humans. Our findings suggest a unique role for CARD8 inflammasome activation in response to lentiviral infection of humans.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jul</publication><modification>2024-11-06T10:36:18.612Z</modification><creation>2024-11-06T10:36:18.612Z</creation></dates><accession>S-EPMC10359095</accession><cross_references><pubmed>37417868</pubmed><doi>10.7554/eLife.84108</doi></cross_references></HashMap>